Memory Enhancement Center

Dimebon a failure in the treatment of Alzheimer’s Disease patients

Joel Ross — Fri, 05 Mar 2010 17:37:13 +0000

“The Alzheimer’s Association is disappointed to learn of the negative results from the Phase III clinical trial of latrepirdine (Dimebon),” said William Thies, Ph.D., Alzheimer’s Association Chief Medical and Scientific Officer. “People with Alzheimer’s, their families and caregivers desperately need more and better treatment options for this devastating, fatal brain disease.” Nonetheless, the Alzheimer’s Association remains [...]

Real World Study of FDA approved Alzheimer’s Disease Drugs: Pause for ?Concern

Joel Ross — Thu, 04 Feb 2010 15:50:50 +0000

In the many years I have been working with pharmaceutical testing of new AD compounds, the real world benefit of the below mentioned drugs has always been a very important question. Perhaps now my readers will see a different slant of the benfits/risks of such meds. I report the below article for my readers to [...]

Even minor memory lapses could be significant!!!

Joel Ross — Mon, 11 Jan 2010 18:07:04 +0000

Senior moments? Age related memory loss? Should you worry? Maybe so. Read below! Healthy older adults with subjective memory loss may be at increased risk for MCI and dementia Forgot where you put your car keys? Having trouble recalling your colleague’s name? If so, this may be a symptom of subjective cognitive impairment (SCI), the earliest sign [...]

Will Dimebon be the next FDA approved Drug for AD?

Joel Ross — Mon, 11 Jan 2010 17:51:56 +0000

I have been very actively researching Dimebon in clinical research studies under strict FDA and industry guidelines, and saw the below article and felt my readers would be most interested in learning more about an “outsider” looking in at the potential for this drug if FDA approved for Alzheimer’s Disease. For the Treatment of Alzheimer’s Disease, [...]

What’s the latest with “nutriceuticals” on memory loss?

Joel Ross — Mon, 11 Jan 2010 16:41:12 +0000

Below is a nutriceutal approach to Alzheimer’s Disease. Small study with interesting results. The results will need to be replicated in a larger study of 1000 patients before I can be convinced of its true benefit to patients. New approach to fighting Alzheimer’s shows potential in clinical trial Nutrient mix shows promise in improving memory CAMBRIDGE, Mass. — [...]